References
Glund S,et al. Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial Lancet : 15 Jun 2015. Available from: URL: http://dx.doi.org/10.1016/S0140-6736(15)60732-2
Treschan TA, et al. Antidotes for anticoagulants: a long way to go. Lancet : 15 Jun 2015. Available from: URL: http://dx.doi.org/10.1016/S0140-6736(15)61086-8
Rights and permissions
About this article
Cite this article
Idarucizumab safe for reversal of dabigatran-induced anticoagulation. Reactions Weekly 1558, 9 (2015). https://doi.org/10.1007/s40278-015-2998-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-2998-z